Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

BUY
$34.5 - $42.19 $26.3 Million - $32.2 Million
762,413 Added 210.72%
1,124,230 $47.4 Million
Q1 2023

May 11, 2023

SELL
$33.32 - $40.98 $14 Million - $17.2 Million
-418,847 Reduced 53.65%
361,817 $12.9 Million
Q4 2022

Feb 09, 2023

BUY
$25.32 - $51.45 $19.8 Million - $40.2 Million
780,664 New
780,664 $28.6 Million
Q1 2022

May 09, 2022

SELL
$74.15 - $99.36 $1.29 Million - $1.73 Million
-17,455 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$86.01 - $102.89 $5.75 Million - $6.87 Million
-66,799 Reduced 79.28%
17,455 $1.79 Million
Q3 2021

Nov 12, 2021

SELL
$84.7 - $96.31 $2.29 Million - $2.61 Million
-27,087 Reduced 24.33%
84,254 $7.37 Million
Q2 2021

Aug 12, 2021

BUY
$76.44 - $89.57 $8.51 Million - $9.97 Million
111,341 New
111,341 $9.96 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.